3,4-dihydroxyphenylacetic acid has been researched along with indazoles in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 11 (42.31) | 18.2507 |
| 2000's | 11 (42.31) | 29.6817 |
| 2010's | 3 (11.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clemens, JA; Fuller, RW; Latz, JE; Mason, NR; McQuaid, LA; Wong, DT | 1 |
| Dawson, TM; Dawson, VL; Jackson-Lewis, V; Przedborski, S; Shibata, T; Yokoyama, R | 1 |
| Beal, MF; Brouillet, E; Dolan, R; Ferrante, R; Hantraye, P; Matthews, RT; Palfi, S | 1 |
| Ali, SF; Itzhak, Y | 1 |
| Di Monte, DA; Jakowec, MW; Langston, JW; Royland, JE | 1 |
| Hindmarsh, JG; Jenner, P; Marsden, CD; Rose, S; Silva, MT | 1 |
| Ambrosio, S; Cutillas, B; Espejo, M | 1 |
| Callahan, BT; Ricaurte, GA | 1 |
| Bert, L; Denoroy, L; Desvignes, C; Lambás-Señas, L; Renaud, B; Vinet, L | 2 |
| Hindmarsh, JG; Jenner, P; Rose, S | 1 |
| Castagnoli, K; Castagnoli, N; Palmer, S | 1 |
| Ali, SF; Imam, SZ; Islam, F; Itzhak, Y; Slikker, W | 1 |
| O'Byrne, MB; Tipton, KF | 1 |
| Brus, R; Kostrzewa, RM; Nowak, P; Oświecimska, J; Sokoła, A | 1 |
| Choi, KH; Chung, MW; Chung, SY; Hwang, O; Jeong, W; Kang, JH; Kim, DS; Kim, Ji; Lee, SY; Lim, HK; Park, CS; Park, IS; Park, Y | 1 |
| Araki, T; Imai, Y; Itoyama, Y; Kato, H; Kurosaki, R; Matsubara, M; Michimata, M; Mikami, T; Muramatsu, Y | 1 |
| Araki, T; Imai, Y; Kurosaki, R; Matsubara, M; Michimata, M; Muramatsu, Y; Watanabe, H | 1 |
| Emmanouil, DE; Hagihara, PT; Papadopoulou-Daifoti, Z; Quock, DG; Quock, RM | 1 |
| Araki, T; Kato, H; Watanabe, Y | 1 |
| Araki, T; Kato, H; Takagi, S; Watanabe, Y; Yokoyama, H | 1 |
| Aoki, E; Araki, T; Kato, H; Yano, R; Yokoyama, H | 1 |
| Benigno, A; Crescimanno, G; Di Giovanni, G; Di Matteo, V; Esposito, E; Pierucci, M | 1 |
| Benigno, A; Crescimanno, G; Di Giovanni, G; Di Matteo, V; Esposito, E; Orbán, G; Pierucci, M | 1 |
| Alfonso, M; Durán, R; Faro, LR; Ferreira Nunes, BV; Ferreira, VM | 1 |
| Ehara, A; Nakadate, K; Sugimoto, H; Ueda, S; Yoshimoto, K | 1 |
26 other study(ies) available for 3,4-dihydroxyphenylacetic acid and indazoles
| Article | Year |
|---|---|
Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cell Membrane; Corpus Striatum; Dopamine; Dopamine Agents; Ergolines; Homovanillic Acid; Indazoles; Molecular Structure; Prolactin; Pyrazoles; Rats; Structure-Activity Relationship | 1989 |
Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cerebellum; Corpus Striatum; Dopamine; Dopamine Agents; Enzyme Inhibitors; Homovanillic Acid; Humans; Indazoles; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; MPTP Poisoning; Nerve Degeneration; Neurons; Nitric Oxide; Nitric Oxide Synthase; Parkinson Disease; Substantia Nigra | 1996 |
Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Disease Models, Animal; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Hypokinesia; Indazoles; Male; Motor Activity; Neurologic Examination; Neurons; Nitric Oxide Synthase; Papio; Parkinson Disease, Secondary; Substantia Nigra; Videotape Recording | 1996 |
The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Carrier Proteins; Cell Membrane; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Homovanillic Acid; Indazoles; Kinetics; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Nerve Tissue Proteins; Neurons; Neurotoxins; Nitric Oxide Synthase; Reference Values | 1996 |
Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Dopamine Agents; Enzyme Inhibitors; Homovanillic Acid; Indazoles; Male; Methamphetamine; Mice; Neostriatum; Neuroprotective Agents; Neurotoxins; Nitric Oxide; Nitric Oxide Synthase; Parkinson Disease, Secondary; Tyrosine 3-Monooxygenase | 1996 |
L-arginine produces NO-independent increases in dopamine efflux in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arginine; Citrulline; Corpus Striatum; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Indazoles; Male; Microdialysis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Stereoisomerism | 1998 |
7-Nitroindazole prevents dopamine depletion caused by low concentrations of MPP+ in rat striatal slices.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; In Vitro Techniques; Indazoles; Male; Rats; Rats, Sprague-Dawley | 1998 |
Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Indazoles; Male; Methamphetamine; Mice; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Temperature | 1998 |
Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, Micellar Electrokinetic Capillary; Dopamine; Enzyme Inhibitors; Extracellular Space; Indazoles; Male; Microdialysis; Monoamine Oxidase Inhibitors; Neostriatum; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pargyline; Rats; Rats, Sprague-Dawley | 1999 |
Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Electrophysiology; Enzyme Inhibitors; Extracellular Space; Indazoles; Male; Microdialysis; Monoamine Oxidase Inhibitors; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pargyline; Rats; Rats, Sprague-Dawley | 1999 |
Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydroxybenzoates; Hydroxyl Radical; In Vitro Techniques; Indazoles; Male; Microdialysis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Wistar | 1999 |
Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cattle; Corpus Striatum; Dopamine; Indazoles; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Neuroprotective Agents; Neurotoxins; Selegiline | 1999 |
Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: implications for the prevention of methamphetamine-induced neurotoxic damage.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Cyclic N-Oxides; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Interactions; Electrochemistry; Free Radical Scavengers; Homovanillic Acid; Imidazoles; Indazoles; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Models, Biological; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide; Peroxynitrous Acid; Tyrosine | 2000 |
Inhibition of the neuronal isoform of nitric oxide synthase significantly attenuates 1-methyl-4-phenylpyridinium (MPP(+)) toxicity in vitro.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Homovanillic Acid; In Vitro Techniques; Indazoles; L-Lactate Dehydrogenase; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroarginine; Rats; Rats, Wistar | 2002 |
7-Nitroindazole enhances amphetamine-evoked dopamine release in rat striatum. an in vivo microdialysis and voltammetric study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Electrophysiology; Enzyme Inhibitors; Homovanillic Acid; Indazoles; Male; Microdialysis; Molsidomine; Nitric Oxide Donors; Rats; Rats, Wistar | 2002 |
Aroclor 1254-induced cytotoxicity in catecholaminergic CATH.a cells related to the inhibition of NO production.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cell Line; Cell Survival; Chlorodiphenyl (54% Chlorine); Dopamine; Indazoles; L-Lactate Dehydrogenase; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Penicillamine | 2002 |
Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Arginine; Brain Chemistry; Dopamine; Dopamine Agents; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Immunohistochemistry; Indazoles; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Neostriatum; Neurotoxicity Syndromes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pargyline; Tyrosine 3-Monooxygenase | 2002 |
Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Glial Fibrillary Acidic Protein; Immunohistochemistry; Indazoles; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Monoamine Oxidase Inhibitors; MPTP Poisoning; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pargyline; Parvalbumins; Protective Agents; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2004 |
A study of the role of serotonin in the anxiolytic effect of nitrous oxide in rodents.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Cinanserin; Corpus Striatum; Dopamine; Fluoxetine; Frontal Lobe; Hippocampus; Hydroxyindoleacetic Acid; Hypothalamus; Indazoles; Male; Mice; Nitrous Oxide; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT2; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin; Tropanes | 2006 |
Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antibodies; Astrocytes; Behavior, Animal; Blotting, Western; Dopamine; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Homovanillic Acid; Immunohistochemistry; Indazoles; Intermediate Filament Proteins; Male; Mice; Mice, Inbred C57BL; Microglia; Motor Activity; MPTP Poisoning; Nerve Tissue Proteins; Nestin; Neurons; Nitric Oxide Synthase Type I; S100 Proteins; Stem Cells; Tyrosine 3-Monooxygenase | 2008 |
Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Cytoprotection; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activators; Enzyme Inhibitors; Free Radical Scavengers; Glial Fibrillary Acidic Protein; Gliosis; Homovanillic Acid; Indazoles; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Parkinsonian Disorders; Reactive Nitrogen Species; Reactive Oxygen Species; Tyrosine 3-Monooxygenase | 2008 |
Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipyrine; Cyclooxygenase Inhibitors; Dopamine; Edaravone; Enzyme Activators; Enzyme Inhibitors; Etodolac; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Homovanillic Acid; Indazoles; Indoles; Indomethacin; Male; Mice; Mice, Inbred C57BL; Minocycline; MPTP Poisoning; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Quinolines | 2008 |
Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: Electrophysiological and neurochemical evidence in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Action Potentials; Analysis of Variance; Animals; Arginine; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Indazoles; Male; Microdialysis; Neurons; NG-Nitroarginine Methyl Ester; Nicotine; Nicotinic Agonists; Nitric Oxide; Rats; Rats, Sprague-Dawley; Substantia Nigra; Time Factors | 2010 |
Electrophysiological and neurochemical characterization of 7-nitroindazole and molsidomine acute and sub-chronic administration effects in the dopaminergic nigrostrial system in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Action Potentials; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Drug Administration Schedule; Enzyme Inhibitors; Indazoles; Male; Molsidomine; Neural Pathways; Neurons; Nitric Oxide Donors; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2009 |
Role of glutamate receptors and nitric oxide on the effects of glufosinate ammonium, an organophosphate pesticide, on in vivo dopamine release in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; 6-Cyano-7-nitroquinoxaline-2,3-dione; Aminobutyrates; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Herbicides; Homovanillic Acid; Indazoles; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2013 |
Role of neuronal nitric oxide synthase in slowly progressive dopaminergic neurodegeneration in the Zitter rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Base Sequence; Caudate Nucleus; Dopamine; Dopaminergic Neurons; Enzyme Inhibitors; Indazoles; Lipid Peroxidation; Male; Membrane Proteins; Nerve Degeneration; Neuroprotective Agents; Nitric Oxide Synthase Type I; Pars Compacta; Putamen; Rats; RNA, Messenger; Sequence Deletion; Vacuoles | 2018 |